Inve US ▾
MVMVST

Microvast (MVST) Q2 FY26 earnings call

Earnings call· Jun 2026 (Q2 FY26)· Industrials· Aug 10, 2026

Source: earnings call transcript

Executive summary

Microvast Q2 FY26 — Revenue Decline Offset by European Growth and R&D Progress

Microvast reported a challenging Q2 FY26 with a revenue decline primarily due to a tariff refund and reduced sales volumes, alongside gross margin compression from higher raw material costs. Despite these headwinds, the company saw strong growth in European sales and made significant progress in its R&D initiatives, particularly with solid-state battery technology. Operational expansions in Huzhou and Clarksville are advancing, though the latter's battery plant remains contingent on financing.

Highlights

4
  • European sales increased 35% in Q2 FY26 compared to the prior year period, accounting for 61% of quarterly revenue.

  • Huzhou Phase 3.2 expansion installation and commissioning completed, with production capacity ramping up for SOP in 2026, adding up to 2 GWh annual capacity.

  • Solid-state bipolar cell architecture prototype demonstrated durability, retaining approximately 88.5% capacity after 200 cycles.

  • Net cash generated by financing activities increased by $15 million for the 6 months ended June 30, 2026, compared to the same period in 2025.

Concerns

5
  • Revenue for Q2 FY26 was $87.3 million, a decrease of 4.5% year-over-year, primarily due to a $2.7 million tariff refund.

  • Gross margin decreased to 29.5% in Q2 FY26 from 34.7% in Q2 FY25, driven by higher raw material prices and lower production utilization.

  • GAAP net loss was $12 million in Q2 FY26, and non-GAAP adjusted EBITDA was $3.6 million, down from $25.9 million in Q2 FY25.

  • Net cash used in operating activities was $33.3 million for the 6 months ended June 30, 2026, a decrease of $77.6 million compared to the prior year.

  • APAC sales declined 23% in Q2 FY26 and 45% year-to-date, due to shifting regulatory/geopolitical dynamics and demand for lower-cost products.

Segment performance

SegmentRevenueYoYQoQMargin
Europe
Sales increased 35% in the quarter compared to the prior year period. Year-to-date sales were down 3%, impacted by customer platform rollout delays in the previous quarter.
Share of quarterly revenue: 61%Share of quarterly revenue (prior year): 43%
—35%——
APAC
Sales declined 23% in the quarter compared to the prior year period, with year-to-date sales down 45%. This is due to shifting regulatory and geopolitical dynamics and a demand shift towards lower cost products in India.
Year-to-date sales decline: 45%
—-23%——

Product announcements

ProductTypeDetails
Series-connected bipolar cell architecturemilestone
All-solid-state silicon-sulfur cellroadmap

Capital programs

Huzhou Phase 3.2 manufacturing facility expansion underway

Benefit:up to 2 GWh annual production capacity

Installation and commissioning of production equipment is completed with production capacity ramping up. Expected to be modular across large battery cell platform.

Clarksville, Tennessee pack line assembly on schedule

Benefit:initial output

Pack line assembly remains on schedule for initial output by year-end.

Clarksville, Tennessee battery plant construction contingent
Funding: additional financing or strategic partnerships

Construction at the site remains contingent on securing additional financing or strategic partnerships.

Risks & headwinds

Revenue reduction due to tariff refund Q2 FY26

$2.7 million reduction in Q2 FY26 revenue

Mitigation:Not explicitly stated, but the refund was issued to a customer.

Gross margin compression Q2 FY26

Decreased to 29.5% in Q2 FY26 from 34.7% in Q2 FY25

Mitigation:Focus on protecting gross margins and deploying targeted innovations for high-margin customer commitments.

Higher raw material prices Q2 FY26

Primary driver for gross margin decrease

Mitigation:Not explicitly stated.

Lower production utilization Q2 FY26

Reduced fixed cost absorption, contributing to gross margin decrease

Mitigation:Ramping up production capacity at Huzhou Phase 3.2.

Increased operating expenses Q2 FY26

16.1% increase year-over-year in Q2 FY26

Mitigation:Tightening operational execution to streamline transition from R&D to production.

Decline in APAC sales Q2 FY26 and YTD

23% decline in Q2 FY26, 45% year-to-date

Mitigation:Not explicitly stated, but attributed to shifting regulatory/geopolitical dynamics and demand for lower-cost products.

Clarksville battery plant financing contingency Ongoing

Construction contingent on securing additional financing or strategic partnerships

Mitigation:Actively seeking additional financing or strategic partnerships.

Net cash used in operating activities 6 months ended June 30, 2026

$33.3 million used for 6 months ended June 30, 2026

Mitigation:Accelerating path to profitability.

What to watch in Q3 FY26

Huzhou Phase 3.2 SOP and production ramp

H2 FY26
Current Installation and commissioning completed, ramping up production
Target SOP in 2026 and full production capacity

Why it matters

This expansion is a central catalyst for 2026, crucial for meeting next-generation cell demand and improving fixed cost absorption.

Operationally, Huzhou Phase 3.2 remains our central catalyst of 2026, with equipment commissioning progressing toward a series production later this year to support next-generation cell demand domestically pack line assembly in Clarksville, Tennessee remains on schedule for initial output by year-end.

Find out whether MVST delivers this. Inve re-checks your case every morning.

3 min read 7 chapters

Detailed narrative

Q2 FY26 Financial Performance Overview

Microvast reported Q2 FY26 revenue of $87.3 million, a 4.5% decrease year-over-year, primarily impacted by a $2.7 million tariff refund. Gross profit was $25.8 million with a gross margin of 29.5%, down from 34.7% in Q2 FY25, mainly due to higher raw material prices and lower production utilization.

Operating expenses increased 16.1% year-over-year to $27.5 million, driven by higher legal fees and R&D labor costs. The company recorded a GAAP net loss of $12 million and an adjusted net loss of $5.3 million, with non-GAAP adjusted EBITDA at $3.6 million.

Regional Revenue Performance

U.S. sales decreased year-over-year, affected by the $2.7 million tariff refund and a customer pulling product into 2025 due to tariff uncertainty. European sales demonstrated strong growth, increasing 35% in the quarter and contributing 61% of total quarterly revenue, up from 43% last year.

Conversely, APAC sales declined significantly by 23% in the quarter and 45% year-to-date, attributed to shifting regulatory and geopolitical dynamics, as well as a demand shift towards lower-cost products in India.

Cash Flow Performance

Net cash used in operating activities for the 6 months ended June 30, 2026, was $33.3 million, a substantial decrease of $77.6 million compared to cash generated in the prior year, primarily due to a $60.6 million reduction in net income (adjusted for noncash items) and a $17 million net change in operating assets and liabilities.

Net cash used in investing activities was $3.3 million, mainly for a U.S. office building and Huzhou Phase 3.2 expansion. Net cash generated by financing activities increased by $15 million to $8.2 million, driven by bank borrowings. The quarter ended with $143.1 million in cash, cash equivalents, and restricted cash.

Huzhou Phase 3.2 Expansion & Clarksville Plant Update

The Huzhou Phase 3.2 expansion has completed installation and commissioning of production equipment, with production capacity currently ramping up. SOP (Start of Production) is expected in 2026, adding up to 2 gigawatt-hours of annual production capacity for large battery cell platforms.

In the U.S., the pack line assembly in Clarksville, Tennessee, remains on schedule for initial output by year-end 2026. However, the construction of the larger battery plant at the Clarksville site is contingent on securing additional financing or strategic partnerships.

Solid-State Battery R&D Progress

Microvast achieved a milestone with its series-connected bipolar cell architecture, successfully scaling a 17-layer monolithic stack to approximately 72 volts with no liquid electrolyte in laboratory tests. This prototype retained about 88.5% capacity after 200 cycles. The design targets robotics applications, aiming to eliminate heavy interconnects and enhance safety.

Hotbox testing up to 200°C showed exceptional stability with no ignition or smoke, even after internal short events, demonstrating significant safety potential.

Ultra-High-Capacity Chemistries

The company is exploring ultra-high-capacity chemistries, including an all-solid-state silicon-sulfur cell. Early laboratory prototypes achieved an initial specific capacity of over 1,000 milliampere-hours per gram, retaining over 90% capacity after 15 cycles. A 5-layer bipolar design uses simultaneous cathode expansion and anode contraction to self-compensate for volume changes during cycling, mitigating contact loss.

This technology is targeted for commercial and defense drones, potentially increasing flight endurance and payload capacity by eliminating external pressure fixtures.

Strategic Priorities for H2 FY26

Microvast's strategic priorities for the second half of 2026 include accelerating the path to profitability, scaling with margin discipline, and expanding into high-barrier heavy industry and transit markets. The company is focusing on tightening operational execution, protecting gross margins, and deploying targeted innovations like the KAF electric powertrain for high-margin customer commitments.

Huzhou Phase 3.2 is a central catalyst for 2026, supporting next-generation cell demand, while Clarksville's pack line is on track for year-end output.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.